Your browser doesn't support javascript.
loading
Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?
Saygili, Emre Sedar; Elhassan, Yasir S; Ronchi, Cristina L.
Afiliação
  • Saygili ES; Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale, Turkey; Institute of Metabolism and Systems Research, College of Medical and Dental Science, University of Birmingham, Birmingham B15 2TT, UK.
  • Elhassan YS; Institute of Metabolism and Systems Research, College of Medical and Dental Science, University of Birmingham, Birmingham B15 2TT, UK; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK.
  • Ronchi CL; Institute of Metabolism and Systems Research, College of Medical and Dental Science, University of Birmingham, Birmingham B15 2TT, UK; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK. Electronic address: C.L.Ronchi@bham.ac.uk.
Lancet Digit Health ; 6(3): e154, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38395534
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Dopamina / Neoplasias das Glândulas Suprarrenais Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Dopamina / Neoplasias das Glândulas Suprarrenais Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article